Felice Gragnano,David van Klaveren,Dik Heg,Lorenz Räber,Mitchell W Krucoff,Sergio Raposeiras-Roubin,Jurriën M Ten Berg,Sergio Leonardi,Takeshi Kimura,Noé Corpataux,Alessandro Spirito,James B Hermiller,Emad Abu-Assi,Dean Chan Pin Yin,Jaouad Azzahhafi,Claudio Montalto,Marco Galazzi,Sarah Bär,Raminta Kavaliauskaite,Fabrizio D'Ascenzo,Gaetano M De Ferrari,Hirotoshi Watanabe,Philippe Gabriel Steg,Deepak L Bhatt,Paolo Calabrò,Roxana Mehran,Philip Urban,Stuart Pocock,Stephan Windecker,Marco Valgimigli

Abstract:Background: Accurate bleeding risk stratification after percutaneous coronary intervention (PCI) is important for treatment individualization. However, there is still an unmet need for a more precise and standardized identification of high bleeding risk patients. We derived and validated a novel bleeding risk score by augmenting the PRECISE-DAPT score with the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria. Methods: The derivation cohort comprised 29,188 patients undergoing PCI, of whom 1136 (3.9%) had a Bleeding Academic Research Consortium (BARC) 3 or 5 bleeding at 1 year, from four contemporary real-world registries and the XIENCE V USA trial. The PRECISE-DAPT score was refitted with a Fine-Gray model in the derivation cohort and extended with the ARC-HBR criteria. The primary outcome was BARC 3 or 5 bleeding within 1 year. Independent predictors of BARC 3 or 5 bleeding were selected at multivariable analysis (p<0.01). The discrimination of the score was internally assessed with apparent validation and cross-validation. The score was externally validated in 4578 patients from the MASTER DAPT trial and 5970 patients from the STOPDAPT-2 total cohort. Results: The PRECISE-HBR score (age, estimated glomerular filtration rate, hemoglobin, white-blood-cell count, previous bleeding, oral anticoagulation, and ARC-HBR criteria) showed an area under the curve (AUC) for 1-year BARC 3 or 5 bleeding of 0.73 (95% CI, 0.71-0.74) at apparent validation, 0.72 (95% CI, 0.70-0.73) at cross-validation, 0.74 (95% CI, 0.68-0.80) in the MASTER DAPT, and 0.73 (95% CI, 0.66-0.79) in the STOPDAPT-2, with superior discrimination than the PRECISE-DAPT (cross-validation: Δ AUC, 0.01; p=0.02; MASTER DAPT: Δ AUC, 0.05; p=0.004; STOPDAPT-2: Δ AUC, 0.02; p=0.20) and other risk scores. In the derivation cohort, a cut-off of 23 points identified 11,414 patients (39.1%) with a 1-year BARC 3 or 5 bleeding risk ≥4%. An alternative version of the score, including acute myocardial infarction on admission instead of white-blood-cell count, showed similar predictive ability. Conclusions: The PRECISE-HBR score is a contemporary, simple 7-item risk score to predict bleeding after PCI, offering a moderate improvement in discrimination over multiple existing scores. Further evaluation is required to assess its impact on clinical practice.

Predictive Factors for Bleeding Risk in Patients Undergoing Valvular Surgery

Blood Conservation Strategies in Cardiac Valve Replacement

Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding after TAVR

Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

Meta-analysis of Predictors of Early Severe Bleeding in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR

Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study

Machine Learning-Based Prediction of Intraoperative Red Blood Cell Transfusion in Aortic Valve Replacement Surgery

The Association Between Preoperative Blood Calcium and Postoperative Blood Loss in Patients Undergoing Heart Valve Replacement Surgery

Perioperative Safety Evaluation of Gastrointestinal Surgery in Patients with Prosthetic Valves.

POBS-Card, a new score of severe bleeding after cardiac surgery: Construction and external validation

A Risk Prediction Model for Adverse Events after Surgical Valve Replacement

Aetiology and predictors of major bleeding events in patients with heart failure with reduced ejection fraction undergoing percutaneous coronary intervention

Role of Preoperative Inflammatory Blood Cell Indexes as a Postoperative Risk Predictor Among Patients Undergoing On‐Pump Cardiac Surgery

Construction and validation of risk prediction model for gastrointestinal bleeding in patients after coronary artery bypass grafting

Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention

Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study

Machine learning algorithms to predict major bleeding after isolated coronary artery bypass grafting

Risk Factors of Sudden Cardiac Arrest during the Postoperative Period in Patient Undergoing Heart Valve Surgery

Fatores Preditores de Risco de Sangramento em Pacientes Submetidos a Cirurgia Valvar

Prevention of Perioperative Bleeding in Patients With Chronic Limb-Threatening Ischemia